Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

TNYA

NASDAQ

Tenaya Therapeutics (TNYA)

0.6977 USD −1.15% vs prior close Aug 26, 2026
Tenaya Therapeutics, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Market cap
159.0M USD
EPS, diluted, year to Dec 2025
−0.59 USD
52-week range
0.5527 USD – 2.09 USD
Avg volume
153.5K

as of Aug 26, 2026

Have Tenaya Therapeutics (TNYA) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, Tenaya Therapeutics insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 17 Nov 2025, show no open-market purchase.

Form 4, 90 days to 22 Nov 2026, newest reported trade 17 Nov 2026

0buys
2sells
$2Knet sold
2other filings
Have Tenaya Therapeutics (TNYA) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
17 Nov 2026Ali FarazChief Executive OfficerSell3,4991K USD
17 Nov 2026Tingley WhittemoreChief Medical OfficerSell3,2231K USD
Sold2 open-market sales6,722$2K
2 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Tenaya Therapeutics (TNYA) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
10 Sep 2026Ali FarazChief Executive OfficerAward122,000
10 Sep 2026Tingley WhittemoreChief Medical OfficerAward49,000

Which funds hold Tenaya Therapeutics (TNYA)?

5 of the 45 institutional funds we track reported a Tenaya Therapeutics position for the quarter ended 30 Sep 2026 — a combined 12.8M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Tenaya Therapeutics (TNYA)?
FundPositionSharesValueShares q/q
Millennium ManagementAdded10,244,8756.2M USD+59.3%
Citadel AdvisorsHeld (±25%)4,505,0832.7M USD−1.4%
Renaissance TechnologiesTrimmed2,960,2001.8M USD−30.9%
Marshall WaceTrimmed2,568,5511.5M USD−26.7%
Two Sigma InvestmentsAdded1,002,817605K USD+163.4%
Point72 Asset ManagementExited

What has been filed or recorded for Tenaya Therapeutics (TNYA)?

The filings we hold for Tenaya Therapeutics, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 28 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Tenaya Therapeutics (TNYA)?
And
28 Oct 2026Fails to deliverShares failed to deliver386 shares154 USD notional · <0.001% of shares out
27 Oct 2026Fails to deliverShares failed to deliver54,805 shares22K USD notional · 0.024% of shares out
26 Oct 2026Fails to deliverShares failed to deliver407 shares159 USD notional · <0.001% of shares out
23 Oct 2026Fails to deliverShares failed to deliver34,948 shares14K USD notional · 0.015% of shares out
22 Oct 2026Fails to deliverShares failed to deliver32,402 shares13K USD notional · 0.014% of shares out
20 Oct 2026Fails to deliverShares failed to deliver28,800 shares11K USD notional · 0.013% of shares out
19 Oct 2026Fails to deliverShares failed to deliver53,017 shares20K USD notional · 0.023% of shares out
13 Oct 2026Fails to deliverShares failed to deliver125 shares71 USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver5,613 shares3K USD notional · 0.002% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.08 USDRevenue $2M
30 Sep 2026FinancialsTotal assets76.7M USDat period end
30 Sep 2026FinancialsTotal equity54.5M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.20 USDRevenue $1M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.09 USDRevenue $0M
31 Dec 2025Annual reportFY 2025 reportedEPS −0.59 USD
31 Dec 2025FinancialsNet income−90.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.59 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.12 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.14 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.24 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −1.31 USD

What do people ask about Tenaya Therapeutics (TNYA)?

From live data
What did Tenaya Therapeutics shares close at?0.6977

Tenaya Therapeutics closed at 0.6977 USD on 26 Aug 2026, down 1.15% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Tenaya Therapeutics’ market cap?159.0M

Tenaya Therapeutics is worth 159.0M USD by market value as of 26 Aug 2026, which is the share price times the shares on issue from its SEC filings.

Have Tenaya Therapeutics insiders bought or sold shares recently?2 sales

In the 90 days to 22 Nov 2026, Tenaya Therapeutics insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 17 Nov 2025, show no open-market purchase. A further 2 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Tenaya Therapeutics?5 of 45

5 of the 45 funds we track reported a Tenaya Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Citadel Advisors and Renaissance Technologies. See Funds

When did Tenaya Therapeutics last report earnings?−0.08

Tenaya Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.08 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings
  9. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words